Cancer Research Funding Awarded to Providence College

NEC member Providence College was recently awarded a National Institute of Health (NIH) grant for cancer research.

With the provided funding of $257,049, the Rev. and Dr. Nicanor Austriaco along with Providence College students will be studying the “Bax inhibitor-1” gene that has been linked to lymphoma, leukemia, and breast and prostrate cancer. Their research project, titled “Genetic Dissection of Yeast Bax Inhibitor Function in UPR and Calcium Signaling,” aims to help develop better treatment for cancer patients whose cancers are linked to the “Bax inhibitor-1” gene. Funding for this joint faculty-student project gives student the opportunity to work together to fight cancer. The grant provides three years of funding, beginning in May 2014

This is the second NIH Academic Research Enhancement Award (AREA) grant awarded to Fr. Austriaco in four years. The award funds small scale research in biomedical and behavioral sciences that supports collaboration between faculty and students.  The New England Council congratulates Providence College on this award and for ongoing efforts to fight cancer.

 

Read more in the Providence Business Journal or Providence College’s press release.

 

 

img_side
mask_sidebar
Recently from the Blog

November 24 Weekly Round-Up: NEC Members Contribute to COVID-19 Crisis Response

11/24/2020 | Read Post

MassDevelopment Issues Bond for New Perkins School Building and Dorm

11/19/2020 | Read Post

In the News

NEC Elects Six Respected Regional Business Leaders to Board of Directors

09/28/2020 | Read Press Release

NEC Announces 2020 New Englanders of the Year

08/25/2020 | Read Press Release